VEGFA and ovarian cancer: A framework of tumor dynamics in ovarian cancer predicted the superiority of primary debulking surgery in a low volume disease setting [63], while other analyses focused on optimizing the sequence of chemotherapy in relation to immunotherapy [64] or targeting VEGF-mediated angiogenesis [65], approaches that can help us better understand the development of treatment resistance and design more efficient clinical trials.